Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Onabotulinumtoxin A for Prevention of Bladder Dysfunction in Acute SCI
NCT01698138Phase 4Completed
- Sponsor
- Oslo University Hospital
- Start
- Sep 2012
- Primary completion
- Dec 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of onabotulinumtoxinA in neurogenic detrusor overactivity (NDO), sponsored by Oslo University Hospital. Started Sep 2012; status: completed.
02
Drugs
onabotulinumtoxinA
03
Conditions
neurogenic detrusor overactivity (NDO)
Beyond the preview
Go deeper on NCT01698138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01698138.